Elevra Lithium

The Business

Elevra owns and operates the North American Lithium (NAL) mine in Quebec, its only producing asset, alongside early-stage interests in Moblan, Carolina and the Ewoyaa project, which is held for sale. NAL processes hard-rock spodumene ore into a lithium concentrate sold almost entirely to a single customer, with roughly 84% of volumes ultimately destined for China. Unlike diversified producers such as Pilbara Minerals, Elevra has one mine, one product and effectively one customer, so any disruption to any of those three has nowhere to hide. Its production cost per tonne sits well above the lowest-cost Australian and South American operators.

Recent Performance

Shares have re-rated sharply as spodumene prices recovered from the 2024 trough of roughly US$800 a tonne to around US$2,400 today. Revenue of US$202m in FY26 reflects a business still transitioning out of legacy, price-lagged offtake contracts that capped realised prices well below the spot benchmark. Group EBITDA margin was just 6.4%, a reminder that the spot price recovery has not yet fully flowed through to the profit and loss statement.

Outlook

Revenue is expected to rise over the next two years as expansion volumes ramp and legacy contracts roll off, before fading again as spodumene prices normalise faster than the added tonnes can offset. Group EBITDA margin, just 6.4% in FY26, should expand meaningfully over the near term as expansion economies of scale kick in, then fade back toward a more modest, mid-cycle level once the price cycle turns. Free cash flow is expected to stay negative through the expansion phase before turning marginally positive further out. The shape of this cycle matters: the near-term improvement is largely a function of volume and legacy contract roll-off, both transient effects, while the terminal, mid-cycle margin depends on where spodumene settles once new global supply is absorbed.

Our Valuation

We derive fair value using a blend of four independent methods: discounted cash flow, trading multiples, asset-based net asset value, and recent transaction comparables. Each approach weighs the mine's replacement cost, how the market prices comparable producers, and NAL's cash-generating capacity differently, and for a marginal, single-asset miner mid-expansion, that blend matters more than any single method taken alone.

Key Risks

Spodumene prices have collapsed by as much as 87% within a single cycle before, falling from over US$6,000 a tonne in 2022 to around US$800 by 2024. A similar reversion below US$1,200 a tonne would make NAL cash-flow negative and turn the current expansion into a value-destroying use of capital; this is the single most important risk to the thesis because it sits largely outside management's control. Roughly three-quarters of group revenue comes from a single customer, and losing that relationship would take six to twelve months to replace, likely at a lower realised price given a weaker negotiating position. Separately, the US$120-140m NAL expansion is the largest capital project this management team has undertaken, and a material cost or schedule overrun could force a dilutive equity raise.

What to Watch

The thesis-defining event is the spodumene price trajectory through H1 CY27, as new African and South American supply comes online and tests whether current prices hold or roll over.

• Q1 FY27 Ewoyaa sale completion — expected to add cash proceeds to the balance sheet, supporting funding of the NAL expansion.
• Mid-CY27 NAL Stage 1 expansion commissioning — a key test of whether the expansion delivers the cost and volume improvements underpinning the growth case.

Company Description

Elevra Lithium is a North American lithium producer formed through a recent merger, with its sole producing asset being the North American Lithium (NAL) mine in Quebec. NAL mines and processes hard-rock spodumene ore into a lithium concentrate for battery supply chains, currently running at roughly 198,000 tonnes a year with an expansion under way to lift capacity toward 240,000 tonnes by FY29. Beyond NAL, the company holds a 60% interest in the earlier-stage Moblan deposit, an early permitting-stage project at Carolina, and the Ewoyaa project in Ghana, currently under agreement for sale. NAL supplies effectively 100% of group revenue today; the other assets represent option value rather than current earnings.

Where the Growth Is

Growth is entirely a function of the NAL expansion, which lifts sales volume by roughly 20% and is expected to bring unit costs down from around US$853 a tonne toward a US$780 target. That volume growth, however, is set against a spodumene price we expect to normalise from currently elevated levels toward a long-run average well below where the market sits today. The two forces largely offset: revenue rises from US$202m in FY26 to a peak near US$275m in FY28, then falls back toward roughly US$244m by FY30 as price normalisation outpaces the extra tonnes. This is a volume story fighting a price headwind, not a clean growth trajectory.

Competitive Position

Elevra's chief advantage is being the only producing hard-rock lithium mine in North America, a position that benefits from Inflation Reduction Act-style incentives and broader critical-minerals policy support favouring non-Chinese supply chains. That advantage is real but narrow: it rests on being first, not on being lowest-cost. A production cost of roughly US$850 a tonne places Elevra in the second or third quartile of the global cost curve, well above Pilbara Minerals' roughly US$450 a tonne. As Patriot Battery Metals and other Quebec-region projects progress toward production later this decade, the North American scarcity premium Elevra currently enjoys should narrow; we estimate this advantage has a shelf life of three to five years rather than being durable. Compounding this, 84% of Elevra's own concentrate is still shipped to China for processing, undercutting the "made in North America" positioning that underpins the policy premium.

Management & Capital Discipline

Management has delivered on the operational side: the recent merger produced roughly US$15m in cost synergies, and production recovered from first-half setbacks including pit wall instability and ore contamination. Capital allocation has been less clean. The company has undertaken multiple dilutive equity raises to fund growth, and the current US$120-140m expansion is the largest capital project this team has executed, with no track record at this scale to draw on. One observation worth flagging: management's commentary has tended to highlight NAL-level cash generation while saying less about negative operating cash flow at the group level, a selective framing investors should read past rather than take at face value.

Financial Position

Elevra holds net cash of roughly US$177m, supplemented by Canada Growth Fund funding tranches and an expected US$71m from the Ewoyaa sale, giving an estimated 22 to 42 months of liquidity runway through the expansion period. There are no material financial covenants constraining the balance sheet. Free cash flow is forecast negative through FY27 and FY28 before turning marginally positive in FY29. The company can fund its current plan without returning to equity markets under our base case, but has little buffer if spodumene prices fall meaningfully during the build.